Kossan Rubber Industries Bhd (KSRBF)
USD 0.34
(26.19%)
USD 0.34
(26.19%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -7.07 Million MYR | -93.38% |
| 2022 | 184.51 Million MYR | -95.04% |
| 2021 | 3.72 Billion MYR | 157.26% |
| 2020 | 1.44 Billion MYR | 402.87% |
| 2019 | 287.69 Million MYR | 8.83% |
| 2018 | 264.35 Million MYR | 12.02% |
| 2017 | 235.98 Million MYR | 9.27% |
| 2016 | 215.95 Million MYR | -21.91% |
| 2015 | 276.55 Million MYR | 43.62% |
| 2014 | 192.56 Million MYR | 4.47% |
| 2013 | 184.32 Million MYR | 27.25% |
| 2012 | 144.85 Million MYR | 20.33% |
| 2011 | 120.38 Million MYR | -19.01% |
| 2010 | 148.63 Million MYR | 56.48% |
| 2009 | 94.99 Million MYR | 13.85% |
| 2008 | 83.43 Million MYR | 21.71% |
| 2007 | 68.55 Million MYR | 23.74% |
| 2006 | 55.4 Million MYR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 34.61 Million MYR | 64.75% |
| 2024 Q1 | 21.01 Million MYR | 1.48% |
| 2023 Q4 | 20.7 Million MYR | -57.87% |
| 2023 Q2 | 2.78 Million MYR | 114.96% |
| 2023 Q3 | 49.13 Million MYR | 1663.04% |
| 2023 FY | 12.21 Million MYR | -93.38% |
| 2023 Q1 | -18.62 Million MYR | 39.05% |
| 2022 Q3 | 28.94 Million MYR | -55.65% |
| 2022 Q1 | 120.86 Million MYR | -50.13% |
| 2022 FY | 184.51 Million MYR | -95.04% |
| 2022 Q4 | -30.55 Million MYR | -205.58% |
| 2022 Q2 | 65.26 Million MYR | -46.01% |
| 2021 Q1 | 1.37 Billion MYR | 81.75% |
| 2021 Q2 | 1.4 Billion MYR | 2.08% |
| 2021 FY | 3.72 Billion MYR | 157.26% |
| 2021 Q3 | 698.24 Million MYR | -50.3% |
| 2021 Q4 | 242.34 Million MYR | -65.29% |
| 2020 Q3 | 438.92 Million MYR | 167.24% |
| 2020 Q2 | 164.24 Million MYR | 90.38% |
| 2020 Q1 | 86.27 Million MYR | 28.38% |
| 2020 Q4 | 757.27 Million MYR | 72.53% |
| 2020 FY | 1.44 Billion MYR | 402.87% |
| 2019 Q3 | 65.54 Million MYR | -12.88% |
| 2019 Q2 | 75.22 Million MYR | -5.64% |
| 2019 Q4 | 67.2 Million MYR | 2.53% |
| 2019 FY | 287.69 Million MYR | 8.83% |
| 2019 Q1 | 79.72 Million MYR | 10.33% |
| 2018 FY | 264.35 Million MYR | 12.02% |
| 2018 Q4 | 72.25 Million MYR | -5.51% |
| 2018 Q3 | 76.46 Million MYR | 29.67% |
| 2018 Q2 | 58.96 Million MYR | 3.53% |
| 2018 Q1 | 56.95 Million MYR | -0.6% |
| 2017 FY | 235.98 Million MYR | 9.27% |
| 2017 Q4 | 57.29 Million MYR | -6.55% |
| 2017 Q3 | 61.31 Million MYR | 4.52% |
| 2017 Q2 | 58.65 Million MYR | -0.11% |
| 2017 Q1 | 58.72 Million MYR | 18.53% |
| 2016 Q2 | 53.34 Million MYR | -21.74% |
| 2016 FY | 215.95 Million MYR | -21.91% |
| 2016 Q1 | 68.16 Million MYR | -13.95% |
| 2016 Q4 | 49.54 Million MYR | 10.32% |
| 2016 Q3 | 44.9 Million MYR | -15.82% |
| 2015 Q4 | 79.21 Million MYR | 7.79% |
| 2015 Q3 | 73.49 Million MYR | 17.4% |
| 2015 FY | 276.55 Million MYR | 43.62% |
| 2015 Q1 | 61.24 Million MYR | 24.31% |
| 2015 Q2 | 62.6 Million MYR | 2.23% |
| 2014 Q2 | 46.73 Million MYR | -4.31% |
| 2014 Q1 | 48.84 Million MYR | 13.6% |
| 2014 Q4 | 49.26 Million MYR | 3.24% |
| 2014 FY | 192.56 Million MYR | 4.47% |
| 2014 Q3 | 47.71 Million MYR | 2.1% |
| 2013 Q2 | 45.71 Million MYR | -1.31% |
| 2013 Q4 | 42.99 Million MYR | -12.8% |
| 2013 FY | 184.32 Million MYR | 27.25% |
| 2013 Q1 | 46.32 Million MYR | 14.58% |
| 2013 Q3 | 49.3 Million MYR | 7.85% |
| 2012 Q1 | 30.28 Million MYR | 0.0% |
| 2012 FY | 144.85 Million MYR | 20.33% |
| 2012 Q2 | 32.63 Million MYR | 7.79% |
| 2012 Q3 | 41.51 Million MYR | 27.19% |
| 2012 Q4 | 40.42 Million MYR | -2.61% |
| 2011 FY | 120.38 Million MYR | -19.01% |
| 2010 FY | 148.63 Million MYR | 56.48% |
| 2009 FY | 94.99 Million MYR | 13.85% |
| 2008 FY | 83.43 Million MYR | 21.71% |
| 2007 FY | 68.55 Million MYR | 23.74% |
| 2006 FY | 55.4 Million MYR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 707.789% |
| Ansell Limited | 129.3 Million USD | 105.473% |
| Ansell Limited | 129.3 Million USD | 105.473% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 122.725% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | -343.441% |
| Psykey, Inc. | -797.5 Thousand USD | -787.268% |
| ConvaTec Group Plc | 262.7 Million USD | 102.694% |
| ConvaTec Group Plc | 262.7 Million USD | 102.694% |
| Encision Inc. | -640.78 Thousand USD | -1004.274% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -4889.775% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -6336.823% |
| Innovative MedTech Inc. | -4.27 Million USD | -65.556% |
| LifePoint, Inc. | -7.49 Million USD | 5.593% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | -9.198% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 2244.242% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | -5657.995% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | -1414.302% |
| SmileDirectClub, Inc. | -241.15 Million USD | 97.066% |
| Sector 10, Inc. | -39.84 Thousand USD | -17659.261% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 102.214% |
| SheerVision, Inc. | 155.72 Thousand USD | 4643.878% |
| United Health Products, Inc. | -2.42 Million USD | -191.609% |
| Vasamed, Inc. | 4.74 Million USD | 249.21% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | -208.438% |
| Yubo International Biotech Limited | -1.2 Million USD | -487.111% |